全球生物技術市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計生物技術市場將從 2025 年的 2.64 兆美元成長到 2034 年的 8.79 兆美元，2026 年至 2034 年的複合年成長率為 14.3%。

隨著生物技術的應用不斷變革醫療保健、農業和工業流程，全球生物技術市場正在快速擴張。生物技術是利用生物系統和生物體開發疫苗、生物製藥、基因改造作物和診斷工具等產品的技術。生命科學研發投入的不斷增加以及對創新醫療手段日益成長的需求是推動市場成長的主要因素。

基因編輯、合成生物學和生物資訊學等技術的進步正顯著加速新型生物技術解決方案的開發。製藥公司和研究機構正擴大利用生物技術開發標靶治療和個人化醫療。政府資助以及學術機構與生技公司之間的合作也正在推動這項產業的發展。

隨著對先進治療方法和永續生物產品的需求不斷成長，生物技術市場預計將進一步擴大。在醫療保健、農業和環境管理等領域的應用不斷拓展，將持續創造新的機會。持續的研究和創新將在塑造生物技術產業的未來方面發揮至關重要的作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球生技市場：依技術分類

• 市場分析、洞察與預測
• 奈米生物技術
• 組織工程與再生醫學
• DNA定序
• 基於細胞的檢測
• 發酵
• PCR技術
• 層析法
• 其他

第5章 全球生技市場：依應用分類

• 市場分析、洞察與預測
• 衛生保健
• 食品和農業
• 自然資源/環境
• 工業流程
• 生物資訊學
• 其他

第6章 全球生技市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • AstraZeneca
  • Gilead Sciences Inc
  • Bristol-Myers Squibb
  • Sanofi
  • Biogen
  • Abbott Laboratories
  • Pfizer Inc
  • Amgen Inc
  • Novo Nordisk A/S
  • Merck KGaA
  • Johnson & Johnson Services Inc

The Biotechnology Market size is expected to reach USD 8.79 Trillion in 2034 from USD 2.64 Trillion (2025) growing at a CAGR of 14.3% during 2026-2034.

The global biotechnology market is experiencing rapid expansion as biotechnology applications continue to transform healthcare, agriculture, and industrial processes. Biotechnology involves the use of biological systems and organisms to develop products such as vaccines, biologic drugs, genetically engineered crops, and diagnostic tools. Increasing investments in life sciences research and the growing demand for innovative medical treatments are major factors driving market growth.

Advancements in technologies such as gene editing, synthetic biology, and bioinformatics are significantly accelerating the development of new biotechnology solutions. Pharmaceutical companies and research institutions are increasingly utilizing biotechnology to develop targeted therapies and personalized medicines. Government funding and collaborations between academic institutions and biotech companies are also strengthening the industry.

Looking ahead, the biotechnology market is expected to grow further as demand for advanced therapies and sustainable bioproducts increases. Expanding applications in healthcare, agriculture, and environmental management will continue to create new opportunities. Continuous research and technological innovation will play a key role in shaping the future of the biotechnology industry.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Nanobiotechnology
• Tissue Engineering and Regeneration
• DNA Sequencing
• Cell-based Assays
• Fermentation
• PCR Technology
• Chromatography
• Others

By Application

• Health
• Food & Agriculture
• Natural Resources & Environment
• Industrial Processing
• Bioinformatics
• Others

COMPANIES PROFILED

• AstraZeneca, Gilead Sciences Inc, BristolMyers Squibb, Sanofi, Biogen, Abbott Laboratories, Pfizer Inc, Amgen Inc, Novo Nordisk AS, Merck KGaA, Johnson Johnson Services Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOTECHNOLOGY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Nanobiotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Tissue Engineering and Regeneration Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. DNA Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cell-based Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Fermentation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. PCR Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOTECHNOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Health Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Food & Agriculture Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Natural Resources & Environment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Industrial Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Bioinformatics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOTECHNOLOGY MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Technology
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Technology
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Technology
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Technology
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Technology
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL BIOTECHNOLOGY INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 AstraZeneca
  • 8.2.2 Gilead Sciences Inc
  • 8.2.3 Bristol-Myers Squibb
  • 8.2.4 Sanofi
  • 8.2.5 Biogen
  • 8.2.6 Abbott Laboratories
  • 8.2.7 Pfizer Inc
  • 8.2.8 Amgen Inc
  • 8.2.9 Novo Nordisk A/S
  • 8.2.10 Merck KGaA
  • 8.2.11 Johnson & Johnson Services Inc